Hah Jennifer M, Vialard Julien D Veron, Efron Bradley, Mackey Sean C, Carroll Ian R, Amanatullah Derek F, Narasimhan Balasubramanian, Hernandez-Boussard Tina
Division of Pain Medicine, Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University, Stanford, CA, USA.
, 1070 Arastradero Rd., Suite 200, Palo Alto, CA, 94304, USA.
Pain Ther. 2023 Oct;12(5):1253-1269. doi: 10.1007/s40122-023-00543-9. Epub 2023 Aug 9.
The evolution of pre- versus postoperative risk factors remains unknown in the development of persistent postoperative pain and opioid use. We identified preoperative versus comprehensive perioperative models of delayed pain and opioid cessation after total joint arthroplasty including time-varying postoperative changes in emotional distress. We hypothesized that time-varying longitudinal measures of postoperative psychological distress, as well as pre- and postoperative use of opioids would be the most significant risk factors for both outcomes.
A prospective cohort of 188 patients undergoing total hip or knee arthroplasty at Stanford Hospital completed baseline pain, opioid use, and emotional distress assessments. After surgery, a modified Brief Pain Inventory was assessed daily for 3 months, weekly thereafter up to 6 months, and monthly thereafter up to 1 year. Emotional distress and pain catastrophizing were assessed weekly to 6 months, then monthly thereafter. Stepwise multivariate time-varying Cox regression modeled preoperative variables alone, followed by all perioperative variables (before and after surgery) with time to postoperative opioid and pain cessation.
The median time to opioid and pain cessation was 54 and 152 days, respectively. Preoperative total daily oral morphine equivalent use (hazard ratio-HR 0.97; 95% confidence interval-CI 0.96-0.98) was significantly associated with delayed postoperative opioid cessation in the perioperative model. In contrast, time-varying postoperative factors: elevated PROMIS (Patient-Reported Outcomes Measurement Information System) depression scores (HR 0.92; 95% CI 0.87-0.98), and higher Pain Catastrophizing Scale scores (HR 0.85; 95% CI 0.75-0.97) were independently associated with delayed postoperative pain resolution in the perioperative model.
These findings highlight preoperative opioid use as a key determinant of delayed postoperative opioid cessation, while postoperative elevations in depressive symptoms and pain catastrophizing are associated with persistent pain after total joint arthroplasty providing the rationale for continued risk stratification before and after surgery to identify patients at highest risk for these distinct outcomes. Interventions targeting these perioperative risk factors may prevent prolonged postoperative pain and opioid use.
在持续性术后疼痛和阿片类药物使用的发展过程中,术前与术后危险因素的演变尚不清楚。我们确定了全关节置换术后延迟疼痛和阿片类药物停用的术前与围手术期综合模型,包括术后情绪困扰随时间变化的情况。我们假设,术后心理困扰的随时间变化的纵向测量以及术前和术后阿片类药物的使用将是这两种结果的最重要危险因素。
斯坦福医院188例接受全髋关节或膝关节置换术的患者组成的前瞻性队列完成了基线疼痛、阿片类药物使用和情绪困扰评估。术后,在3个月内每天评估改良简短疼痛量表,此后每周评估直至6个月,再此后每月评估直至1年。情绪困扰和疼痛灾难化每周评估至6个月,此后每月评估。逐步多变量随时间变化的Cox回归分别对术前变量进行建模,然后对所有围手术期变量(手术前后)与术后阿片类药物停用和疼痛缓解时间进行建模。
阿片类药物停用和疼痛缓解的中位时间分别为54天和152天。围手术期模型中,术前每日口服吗啡当量总用量(风险比-HR 0.97;95%置信区间-CI 0.96-0.98)与术后阿片类药物停用延迟显著相关。相比之下,围手术期模型中随时间变化的术后因素:PROMIS(患者报告结局测量信息系统)抑郁评分升高(HR 0.92;95%CI 0.87-0.98)和疼痛灾难化量表评分较高(HR 0.85;95%CI 0.75-0.97)与术后疼痛缓解延迟独立相关。
这些发现突出了术前阿片类药物使用是术后阿片类药物停用延迟的关键决定因素,而术后抑郁症状和疼痛灾难化的升高与全关节置换术后的持续性疼痛相关,这为在手术前后持续进行风险分层以识别这些不同结局风险最高的患者提供了理论依据。针对这些围手术期危险因素的干预措施可能预防术后疼痛和阿片类药物使用时间延长。